Corrigendum] Ouabain suppresses the growth and migration abilities of glioma U‑87MG cells through inhibiting the Akt/mTOR signaling pathway and downregulating the expression of HIF‑1α.

Abstract

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that several pairings of panels in Fig.5, as shown on p.5599, were strikingly similar. After having examined their original data, the authors realized that they uploaded some images incorrectly during the process of compiling this figure, and that there were duplicated data panels in this figure. However, the authors were able to consult their original data, and had access to the correct images. The revised version of Fig.5, showing the correct data for the Akt/Control, p‑Akt/Control, mTOR/0.05μMOuabain, HIF‑1α/0.05μMOuabain and Akt/0.5μMOuabain experiments, is shown opposite. Note that the replacement of the erroneous data does not affect either the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors are grateful to the Editor of Molecular Medicine Reports for granting them this opportunity to publish a Corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 17: 5595‑5600, 2018; DOI: 10.3892/mmr.2018.8587].